This review focuses on tools for studying a cell's transcriptome, the collection of all RNA transcripts produced at a specific time, and the tools available for determining how these changes in gene expression relate to the functional changes in an organism. While the microarray-based (analog) gene-expression profiling technology has dominated the 'omics' era, Next-Generation Sequencing based gene-expression profiling (RNA-Seq) is likely to replace this analog technology in the future. RNA-Seq shows much promise for transcriptomic studies as the genes of interest do not have to be known a priori, new classes of RNA, SNPs and alternative splice variants can be detected, and it is also theoretically possible to detect transcripts from all biologically relevant abundance classes. However, the technology also brings with it new issues to resolve: the specific technical properties of RNA-Seq data differ to those of analog data, leading to novel systematic biases which must be accounted for when analysing this type of data. Additionally, multireads and splice junctions can cause problems when mapping the sequences back to a genome, and concepts such as cloud computing may be required because of the massive amounts of data generated.
INTRODUCTION
The understanding of biological systems comprising large numbers of genes, approximately 20 000-25 000 protein-coding sequences for humans [1] and at least 22 000 in cattle, broadly similar to gene counts in other mammals [2] is challenging. Fortunately, the tools available for studying a cell's transcriptome and for transforming the large volume of data that these techniques generate into knowledge and new hypotheses have improved over recent years. Traditional methods for gene expression analysis, such as northern blotting, quantitative real-time polymerase chain reaction (qRT-PCR) or differential display, require the pre-selection of single genes. These methods have been and are still useful, but they miss important effects in biological processes, such as metabolic and signaling pathways and transcriptional networks across several pathways [3] because they are confined to the analysis of single genes or a very limited number of selected genes of interest in a few samples. The advent of high-throughput DNA sequencing and the subsequent development of analog gene expression techniques such as microarrays, represented a critical breakthrough as the simultaneous measurement of the expression of many thousands of genes in a sample was finally possible. The recent development of NextGeneration Sequencing and its use in transcriptomic analysis (RNA-Seq) now potentially enables the quantitative measurement of 'all' genes expressed in a sample.
The completion of the Human Genome Project in 2003 [4, 5] , the bovine genome (first draft from 2006 and publication in 2009; http://www.hgsc.bcm.tmc .edu/project-species-m-Bovine.hgsc), followed by other initiatives for porcine and ovine, etc. (see http://www.genomesonline.org/ for a more complete list), and the subsequent availability of complete genomic DNA sequence data are only a few reasons why these newer technologies have advanced so quickly. Initiatives that take advantage of these technologies have been established (Table 1 for examples). These disciplines cover such a diverse scope as nutrition, medicine, parasitology, molecular biology, chemistry, mathematics and bioinformatics in human and livestock research. These programmes are leading recent advances in human and animal genomics [6, 7] .
This review presents an overview of currently existing and emerging transcriptomic technologies, including their advantages and limitations, and data management and analysis strategies and concerns.
Available software solutions and the integration of different data sets are also discussed.
ANALOG METHODS FOR TRANSCRIPTOMIC ANALYSIS Background
The measurement of mRNA levels for a complete set of transcripts in a single assay can be accomplished using DNA and oligonucleotide microarray (chip) technology. This analog high-throughput methodology has become a standard tool for gene expression profiling, facilitating the analysis of genome-wide expression patterns, whether there is a sequenced genome or not (although the sequence of the probes on an array are usually known), to establish gene networks and identify new genes involved in a phenotype.
Microarrays have been used to study many different organisms. Their use includes nutritional studies [3, [8] [9] [10] [11] [12] [13] [14] [15] and livestock research [16] [17] [18] [19] [20] [21] where they are used to characterize metabolic pathways in tissues or cells important to phenotypic outcomes. For example, in cattle, they have been used to investigate folliculogenesis, ovulation and oocyte quality, and early embryonic development [22] .
Array types
Hybridization arrays include macroarrays (spot diameter of each probe >300 mm) and microarrays (spot diameter of each probe <250 mm). Microarrays, the most commonly used of the hybridization arrays, usually consist of a predefined arrangement of a large number of probe (DNA) sequences (whole genome or partial) immobilized on a solid surface that serve as a hybridization substrate for cRNA or cDNA fragments generated from a tissue or cell sample (target). RNA extracted from a tissue or cell sample is amplified and reverse transcribed to produce cDNA labelled with a fluorophore or radiolabel which is hybridized to the microarray chip under stringent conditions. After hybridization is completed, the microarray slides are washed then scanned using a microarray scanner to detect the intensities of the target signal and the background noise [23] . While in-house microarray production still exists (especially for incomplete, non-sequenced or confidential genomes), several commercial platforms offer microarray products of high quality. There are many variants of this technology that can be grouped in two categories based on the length and origin of the spotted DNA: (i) the DNA microarray, where PCR amplicons of a few hundred base pairs of denatured double-stranded DNA are spotted onto glass slides; (ii) the oligonucleotide microarray, where chemically synthesized single-stranded DNA is immobilized on glass slides. For example, the Agilent platform where probes of 40-70 nt in length are tiled; and the Affymetrix platform where 25-mers are tiled, with typically 11-16 25-mers tiled for each gene. For the latter platform, 'mismatch' probes are also tiled for each probe (i.e. the middle nucleotide is replaced with another) to allow adjustment of the data for cross-hybridization, therefore increasing the reliability of the microarray data although at the expense of capacity. More recently, Affymetrix introduced all-exon arrays (HuEx arrays, i.e. Human, Mouse and Rat Exon/Gene 1.0 ST arrays) which differ significantly from the traditional 3 0 -expression arrays described above. Here, exons are covered by only four probes and T7-linked random hexamers used for cDNA synthesis eliminate the need for intact poly-A tails. Studies comparing 3 0 -expression arrays to HuEx arrays reported a high level of cross-platform comparability with only a limited number of recognized problems, such as differences in detection thresholds [24] . Numerous mammalian DNA and oligonucleotide microarrays are available, including for humans, livestock species (e.g. cattle, pig, horse, sheep and chickens) and other mammals (e.g. canine, rabbit, Rhesus macaque, etc). For species where microarrays are less readily available (e.g. goat), cross-species hybridization to existing arrays is possible though not ideal [22, 25] . Custom microarrays can also be used to tile a chosen set of genes of interest.
Additionally, a third category of microarray exists, the beadarray (Illumina platform), which consists of thousands of three-micron silica beads each coated with hundreds of thousands of copies of a specific oligonucleotide sequence, which self-allocate randomly across an array. A decoding process is used to determine which bead occupied each well. Beadarrays typically comprise multiple copies (around 30) of each bead type per array. The beads are combined with more than 1000 control bead types on the arrays (used as negative controls) which, with the random allocation of multiple copies of each bead type, result in high quality data at relatively low cost and sample input [26] .
Variations on the microarray theme [e.g. exon junction arrays, tiling arrays, fusion chips and single nucleotide polymorphism (SNP) chips] allow microarray technology to be used for more than gene expression profiling. Exon junction, tiling and fusion arrays allow detection of alternative splice variants of a (fused) gene [27, 28] . SNP chips allow the identification of SNPs within and between populations [29, 30] enabling uses such as assessing levels of genetic variability including loss of heterozygosity [31, 32] , detection of allelic imbalance [33] and construction of linkage disequilibrium maps which facilitate the association of genetic variation with economically important traits, for example as developed and characterized in bovine [34] [35] [36] . The recent development of an ovine SNP chip containing 1536 SNPs represents the first time that the sheep genome has been assayed on a genome-wide basis. Using the allele frequencies at each SNP, calculation of genetic parameters (e.g. genetic distance) have allowed the levels of genetic variability both within and between a diverse group of ovine populations to be determined. This in combination with cluster analysis has shown that sheep are characterized by weak phylogeographic structure, overlapping genetic similarity and generally low differentiation which is consistent with their short evolutionary history [31] .
Microarray limitations
Microarrays are now an affordable technique that provide RNA expression pattern data based on a high-throughput and semi-quantitative analysis of light signaling intensity. They do, however, have their limitations [37] . The data need to be normalized to remove spatial artefacts and systematic biases, and appropriate statistical analysis must be used to reduce the number of false positives obtained from testing so many genes at once. Furthermore, as the technique relies on hybridization, it brings a range of related potential problems such as background hybridization levels (including cross-hybridization), differential probe hybridization properties and dye binding variances [37] [38] [39] [40] . These variables mean that microarrays do not easily quantify the expression pattern of low abundance transcripts as the low intensity fluorescence signal is difficult to distinguish numerically and statistically from background noise. Conversely, signal saturation can occur at high intensities therefore limiting the ability to compare the level of expression of transcripts which are expressed at very high levels [41] [42] [43] . The information generated with hybridization arrays is also limited to the number of probes on the microarray slide and usually to genes with known sequence. Microarrays are also constrained in their ability to detect splice variants, either because not all the forms are tiled or they are too closely related for hybridization methods to distinguish [42, 44] .
ANALOG-DERIVED TRANSCRIPTOMIC DATA Analysis methods
Determining the biologically significant changes in gene expression levels from a large amount of gene data is still a challenge for microarray-based transcriptomic data.
Analysis of microarrays typically comprises quality control and normalization, followed by determination of a list of differentially expressed genes based on fold change and some type of significance criteria (most commonly used parameter is the P-value). The latter is usually calculated from a t-test, with the recommendation that the variance estimate used should be determined using both gene-specific information and information from across all genes [22, 45, 46] . Volcano plots are an effective way of summarizing the results for the two criteria [46] . Additionally, adjustments for multiple testing are usually applied to control the number of false positives, with the false discovery rate (FDR) [47] a popular choice. Mixture model methods which treat genes as being composed of two populations: one differentially expressed and one not, are also an option [45] .
An alternative analysis approach involves directly determining sets of genes which can be used to successfully differentiate samples from different treatments. The random forest procedure has been shown to be a useful method for doing this as it yields very small sets of genes (often smaller than alternative methods) while preserving predictive accuracy [48] .
Available software
Behind these analysis tools are sophisticated mathematical and statistical models which have been implemented in a variety of open-source and commercial software packages. Some of the most well known packages available include GeneSpring (http:// www.chem.agilent.com/en-US/products/software/ lifesciencesinformatics/genespringgx/Pages/default .aspx), GenStat (http://www.vsni.co.uk/software/ genstat/, [49] ), Spotfire and the Bioconductor suite of microarray analysis packages written in the R programming language (www.bioconductor.org, freely available). The latter includes linear models for microarray analysis (limma, [50] ), affy [37] and simpleaffy [51] for Affymetrix data analysis, lumi [52] for Illumina beadarray analysis and arrayQualityMetrics [53] for quality control.
Most analysis programs accept data from a variety of sources (e.g. Affymetrix, Agilent, Illumina and inhouse data). The Bioconductor suite of packages has the advantage that it is open source and readily accessible, thus facilitating collaborative projects. Many software packages can also be further customized as they include application programming interfaces which allow them to interact directly with other tools. For example, GeneSpring and Spotfire both include modules which allow R code to be used within the package while providing easy interactive visualization of the data and results. A more comprehensive summary of many packages and their interactivity can be found in Supplementary Table S1 of [54] .
Interfaces to a range of underlying tools have also been developed, including Chipster (http://nami .csc.fi/features.shtml, freely available for local installations or alternatively the CSC server can be used for a fee) which allows one to perform DNA microarray data analysis with R/Bioconductor and other tools through an intuitive graphical user interface and GenePattern (freely available). GenePattern was developed at the Broad Institute of Massachusetts Institute of Technology and Harvard University. It is a software environment which incorporates a wide range of already developed tools and has the ability to adopt new methods. The GenePattern platform consequently integrates a large number of analytical tools for genomic data, facilitates data entry and allows parameters to be set with regard to quality control, statistics, gene enrichment analysis, etc. Furthermore, custom modules in R/Bioconductor, MATLAB or the Perl or Java programming languages can be implemented. GenePattern includes 60-100 pre-packaged analysis modules and more complex methodologies (not only for microarray, but also for epigenetic, SNP, proteomic and sequence analyses) aligning analyses into a single, reproducible pipeline that caters for users at all levels of computational experience [54] [55] [56] .
Validation of results
Selected differentially expressed genes are further investigated by qRT-PCR to confirm the expression patterns seen in microarrays. The use of PCR primers targeting transcript variants is one reason for discrepancies between these two methods, thus care has to be taken to design PCR primers which recognize the same transcript as each microarray probe. [57] . The minimum information for publication of quantitative real-time experiments (MIQE) guidelines provide best experimental practice for qRT-PCR to generate data that are more uniform, more comparable and ultimately, more reliable [58] .
RNA-Seq METHODS FOR TRANSCRIPTOMIC ANALYSIS Background
RNA-Seq transcriptomics replaces the hybridization of nucleotide probes with sequencing individual cDNA species followed by counting and mapping algorithms. Emerging methods for these fully quantitative transcriptomic analyses have the potential to overcome the limitations of microarray technology and may replace them. Early attempts reach as far back as 1997 [59] where random clones derived from cDNA libraries were sequenced using fluorescent well and capillary DNA sequencers (i.e. Applied Bio Systems ABI PRISM 373, 377 and 3730xl DNA Sequencer). Variations in gene expression levels were deduced from the counts of respective sequence tags. However, restrictions in technology meant sequencing and analysing large numbers of sequences was slow, expensive and labor intensive so that only a relatively small number of clones (usually in the thousands) were sequenced. Besides the small sample size, cloning bias also introduced new drawbacks.
Today, Next-Generation Sequencing techniques have surpassed these relatively low throughput technologies. In principle, all competing products are based on the sequencing-by-synthesis technique [60] or sequencing-by-ligation (http://www3 .appliedbiosystems.com/cms/groups/mcb_ marketing/documents/generaldocuments/cms_ 058265.pdf). Sequencing-by-synthesis relies on the detection of nucleotides immediately after incorporation into a newly synthesized DNA strand, whereas sequencing-by-ligation involves the binding of known probes to the sequence. While the principle remains unchanged, a number of variants and improvements have been introduced [61] .
Number and length of reads obtained using different platforms [62] ). These systems can also be used for other specific applications such as the targeted resequencing of genomes, ChIP-Seq or copy number variation analyses [63] . NextGeneration Sequencing systems have brought a dramatic change in scale to DNA sequencing. Traditional Sanger Type plate and capillary sequencers can provide up to 96 reads per run, albeit at longer reads length in excess of 1000 nt. Roche 454 Pyrosequencing systems generate hundreds of thousands of reads per run and, with the introduction of the latest Flx-Titanium system upgrade, have extended read length up to 500 nt. This extension in sequence read length has been achieved by the use of a thin metal coating (titanium) that is applied to the pico titer plate walls eliminating crosstalk between individual wells. The coating improves the signal to noise ratio and also increases the number of samples that can be analysed in one plate. Recent announcements by Roche 454 unveiled yet another doubling of read length, targeting the 1000 nt barrier (http://454.com/about-454/news/index.asp?display ¼detail&id¼137). Finally, solid state sequencing systems, such as Illumina or ABI SOLiD, can generate sequence reads in excess of 100 million per run, albeit with the shortcoming of very short read-lengths of <50-100 nt. Indeed, the Applied Biosystems Solid 4 and Solid 5500xl (which delivers on the promise of the Solid 4hq) systems have recently been released with up to 300 Gb mappable data throughput. While the scalability factor reduces the cost per run ($US3000 per genome or $US120 per transcriptome, http://www.appliedbiosystems .com/absite/us/en/home/applications-technologies/ solid-next-generation-sequencing/next-generationsystems/solid4hq.html; http://www.lifetechnologies .com/news-gallery/press-releases/2010/lifetechologies-lauches-ew-solid-sequecer-to-driveadvaces-i-c.html), other potentially limiting factors such as short read lengths of 75 bp or less or the necessity of creating fragment libraries still remain.
RNA-Seq gene expression profiling
Due to their read-length restrictions these ultrahigh-throughput systems may not necessarily be suited for de novo genome sequencing (with the recent exception of 454 pyrosequencing with its longer reads). However, these limitations are irrelevant for RNA-Seq gene expression profiling. Here, the promise of hundreds of millions of reads creates for the first time the realistic opportunity to assess the transcriptome of an organism on a holistic level without cloning bias (although each platform may have its own associated biases, see below) [64, 65] .
Briefly, current technologies utilize a common principle: RNA is converted to a library of cDNA fragments via either RNA or cDNA fragmentation and adapters are attached to one or both ends of the fragments. Individual cDNA species are then amplified into separate clusters to amplify the signal intensity. These clusters are then sequenced from one (single-end sequencing) or both ends (pair-end sequencing) and the reads aligned to a reference genome or transcriptome [43, 65, 66] . The number of sequencing reads mapped to each gene is then tabulated and normalized. In general, the larger the genome and the more complex the transcriptome, the higher the number of reads and the greater the sequencing depth that is required for adequate coverage [43] .
Standard protocols use random fragmentation of cDNA or RNA which means that more than one fragment may be produced from a single transcript. However, different processing methods can be combined with RNA-Seq and give the advantage that only a single tag for each transcript is produced. Such processing methods include serial analysis of gene expression (SAGE) (SOLiD-SAGE; http://tools .invitrogen.com/content/sfs/manuals/SOLiD_ SAGE_man.pdf), cap analysis of gene expression (CAGE) and massively parallel signature sequencing (MPSS) [67] . Disadvantages include that non-coding RNAs may not be detected, the methods rely on the presence of particular restriction sites [68] , and the fragments may be considerably shorter (for example, 27 bp for the SOLiD-SAGE protocol) and therefore do not detect splice isoforms [42] .
More recently, experimental evidence indicates that RNA fragmentation, compared to cDNA fragmentation, may significantly improve the uniformity of sequence coverage across transcripts, so allowing greater sensitivity of detection, accuracy of quantification and completeness of splice and exon maps. RNA fragmentation may work better because of 3 0 -bias induced during cDNA synthesis and also the secondary RNA structure may mean that priming is not truly random but instead some sites are favoured over others [42] .
Additionally, whether a strand-specific protocol is used in RNA-Seq is an important factor to consider [68] , particularly when studying mammals where antisense transcription has been shown to be a ubiquitous phenomenon [69] .
Advantages of RNA-Seq
Initially, Next-Generation Sequencing techniques were used to provide insights into the way genes are expressed and regulated in cells. More recently, they have also been heavily utilized to determine new classes of RNA, SNPs, unknown transcripts, splicing events, etc. which were inaccessible on a global level using older technologies [42, 44, [70] [71] [72] [73] [74] .
The digital nature of RNA-Seq gene expression studies holds the promise of true quantitative analyses [43] . While the implementation of this technique is still in its infancy and essentially in validation stage, its current prohibitive cost is expected to decrease and this technology will become more and more accessible. Out of the currently dominating NextGeneration Sequencing technologies, Illumina and Solid platforms are better suited for RNA-Seq applications than Roche 454 Pyrosequencing. This is largely due to the much greater number of individual sequence reads and the resulting increased depth of coverage. If RNA-Seq is to be combined with de novo genome sequencing, Illumina/Solid data can easily be augmented by paired-end pyrosequencing reads, creating a robust genome scaffold for the shorter Illumina/Solid reads.
RNA-Seq creates the new Gold standard for gene expression studies as transcripts from all biologically relevant abundance classes should theoretically be able to be detected assuming enough reads are collected from a sample [42, 43, 70] . Indeed, using one of the earlier RNA-Seq gene expression technologies (digital gene expression profiling) with 20 million tags per library, 10-20% more transcripts were detected than with microarrays, a majority of which were expressed at levels below the sensitivity threshold of microarray platforms [41] . A comparison of the Illumina sequencing platform with the Affymetrix microarray platform, showed that 81% of differentially expressed genes from arrays were detected with Illumina and more of these genes were true positives with the Illumina technology [71] . Additionally, comparison of relative RNA-Seq read densities to published qRT-PCR measurements for 787 genes in two reference RNA samples yielded a nearly linear relationship across five orders of magnitude, indicating that RNA-Seq read counts give accurate relative gene expression measurements across a very broad dynamic range [44] .
Alternative splice variants have been proposed as a primary driver of the evolution of phenotypic complexity in mammals [44] . The promise that RNA-Seq gene expression studies can easily identify these using direct sequencing may prove to be a major advantage compared to hybridization methods which cannot identify closely related forms except via expensive high-resolution tiling arrays. For example, RNASeq methods found that 3500 mouse genes were alternatively spliced [42] and 4096 previously unknown splice junctions in 3106 human genes were detected in a recent study [70] . Indeed, in humans there is evidence for multiple isoforms for >95% of all multi-exon genes. These transcripts are the result of alternative transcription starts, alternative splicing, RNA editing and alternative poly-adenylation [74] .
RNA-Seq is also useful for discovering novel microRNAs (small RNAs 20-25 nt in length) [75] . However, sequence read variations due to machine error may be higher than the variation found within a microRNA family, so one must be cautious in interpreting this data. Also, the accuracy of RNASeq readings may not necessarily be better than that of microarrays: indeed, a recent study which used synthetic microRNAs found that microarrays measured the expression levels of microRNAs better than RNA-Seq [76] .
Examples of biological applications of RNA-Seq
Although RNA-Seq can be still considered an emerging technology, it has generated new knowledge of biological systems. For example, RNA-Seq was used to characterize the total non-ribosomal transcriptome of human, chimpanzee and rhesus macaque brain [77] . In this study, the authors showed that while transcriptome divergence between species increases with evolutionary time, intergenic transcripts show more expression differences among species and exons show less. These yet uncharacterized evolutionary conserved transcripts that exist in the human brain may play roles in transcriptional regulation and contribute to evolution of human-specific phenotypic traits. Another example relates to the use of a novel, strand-specific RNA-Seq method. Using this method with tumors and matched normal tissue from three patients with oral squamous cell carcinomas, Tuch et al. [78] showed that it accurately measures allelic imbalance and that measurement on the genome-wide scale yields novel insights into cancer etiology. Cancer-related functions such as cell adhesion and differentiation functions were found to be enriched in the set of genes differentially expressed in the tumors, but, unexpectedly, also in the set of allelically imbalanced genes.
RNA-Seq TRANSCRIPTOMIC DATA Volume of data produced
As with the analog technique, a large volume of data is produced. Indeed, the arrival of the RNA-Seq era increased the data volume by several magnitudes and handling of this amount of data is an important consideration, both in terms of collecting and managing the data and the computer hardware (server space) and software required [43, 79, 80] . The amounts of data are so large that if current trends continue, it will soon cost less to sequence a base of DNA than to store it on a hard disk [80] . Alternative data management concepts such as cloud-based computing (essentially renting server space) are already available [81] . For example scientists can currently establish an account with Amazon Web Services or Microsoft Azure, attach any one of several large public genome-oriented data sets to the virtual machine and analyse this data using any one of several installed software packages. There are also a growing number of academic-based clouds, for example the Open Cloud Consortium (http://opencloudconsortium .org/). These may be a better option long-term as academic clouds are more likely to be able to tune their performance to the specific needs of the scientific community, for example data read and write speeds need to be very high for genomic data [80] .
Statistical tests
Various tests of differential expression have been proposed for replicated RNA-Seq data using binomial, Poisson, negative binomial or pseudolikelihood models for the counts [66, 82] . How to best analyse RNA-Seq data is an active field of research. Robinson and Smyth [82] have recently developed a method using the negative binomial distribution to model over-dispersion relative to the Poisson, and use conditional weighted likelihood to moderate the level of over-dispersion across genes. This method is suitable even when the number of replicates is very small. Additionally, methods from the SAGE literature may be useful for analysing RNA-Seq data [66] .
Analysing counts of alternative isoforms creates particular analytical problems. Initial analysis methods, for example the Poisson test, have focused on first assigning reads to transcripts and then testing for differential expression. Stegle et al. [74] describe a modification to this approach, the Poisson Region test, which only utilizes information about the discriminative regions of a gene. They also present a non-parametric kernel method, the Maximum Mean Discrepancy (MMD) test, which directly tests for differences of the observed read distribution from different samples in the complete absence of any annotation information. In comparing these three methods using simulated and real data, the Poisson Region test was the most sensitive. However, the MMD test was still able to detect 75% of the differentially expressed transcripts that the Poisson Region test could. Additionally, the MMD test has the advantage that it can detect differential expression even if only one annotation is currently known for a gene. It also does not depend on the accuracy of existing gene annotations.
Experimental design and quality control
Many issues must be considered when planning an RNA-Seq experiment (Figure 1) . No matter which method is used or how many reads are generated, using generally accepted experimental design principles such as randomization of samples to lanes or plates, and sufficient biological replication are recommended when designing RNA-Seq experiments. Biological replication is essential as otherwise the results from an experiment cannot be generalized. Similarly, randomization and blocking are equally important factors in reducing the effects of batch, lane or flowcell variations. We refer the reader to the excellent paper which Auer and Doerge have recently written [66] . This clearly explains key statistical principles which should be incorporated when designing and analysing RNA-Seq experiments. They also provide practical suggestions, for example barcoding may be a useful tool for creating balanced block designs.
Quality control is also an important aspect of RNA-Seq data analysis. For example, it is useful to plot both the proportions of each nucleotide type, and the base quality scores, for each sequence position. A filter can then be applied to trim the sequence ends if they contain bases which are of low quality or which have atypical nucleotide proportions.
Mapping considerations
With analog expression data, one usually knows what the genes are in advance, whereas with RNA-Seq, all transcripts need to be mapped back to a reference genome or transcriptome.
Difficulties in mapping transcripts to genes can occur and mammalian genomes in particular create difficulties as they are large, complex and often contain families of paralogous genes, repeats and retroposed pseudogenes for highly expressed housekeeping genes. Therefore individual reads, particularly shorter ones, may map to more than one gene. Such multiread transcripts cannot be simply discarded, as these genes, for example those in the ubiquitin family, will then be undercounted or not even reported. Alternative approaches such as distributing multireads in proportion to the number of unique and splice reads recorded at similar loci or using orthogonal data (for example RNA polymerase II occupancy data) have been proposed to help resolve these issues [42, 73] .
Mapping splice junctions is also an important issue to consider when mapping reads from complex mammalian (and other) genomes where reads may span large introns [42, 73] . Two main approaches are currently used: the reference genome may be supplemented with known splice junction information (including information from gene models) or alternatively the splice junctions can be determined without a reference annotation. TopHat (http://tophat .cbcb.umd.edu/; [83] ) is a powerful freely available mapping program which can map reads using any combination of these methods. A range of other mapping programs also exist: see Table 2 in Pepke et al. [73] for an excellent summary. Developing in silico methods to map splice junctions agnostically (i.e. independently of existing genome annotations) is still an active area of research though. Hammer et al. [84] have recently developed a series of novel bioinformatic tools which advance RNA-Seq bioinformatics toward unbiased transcriptome capture. It is likely that further tools and methodology will be developed in the short to medium term.
Normalization and biases
As for the analog transcriptomic analyses, the efficiency of RNA extraction and the quality of cDNA synthesis remain as variables. Additionally, the specific technical properties of RNA-Seq data differ to those of analog data, leading to novel systematic biases which must be accounted for in the analysis.
The number of reads obtained per sample usually differs for RNA-Seq. Thus a range of normalization methods for RNA-Seq based on the total number of reads for each sample have been reported. However it has recently been shown that the composition of the RNA population is also important [85] . Transcripts which are highly expressed in only some samples, due to true biological differences (e.g. genes which are only expressed in liver and not kidney) or contamination, reduce the sequencing 'real estate' available for the remaining genes, meaning that these genes will be under-represented if the data is normalized solely using a total gene count approach. A normalization method, Trimmed Mean of M values (TMM) which accounts for this issue has been proposed by Robinson and Oshlack [85] . The method assumes, similarly to common microarray normalization methods (e.g. loess and quantile) that the majority of genes are not differentially expressed. It then determines the relative RNA production for all genes in a sample using a global fold change approach calculated by using trimmed means. This normalization method can be implemented using the edgeR package in Bioconductor ( [86] ; www.bioconductor .org.).
Furthermore, current RNA-Seq protocols usually use random fragmentation of the RNA (or cDNA) which implies that the expected count for a transcript is proportional to the gene's expression level multiplied by its transcript length, as longer transcripts generate more fragments. This means that longer genes have higher transcript counts and so, relative to shorter genes, are more likely to be found to be differentially expressed, particularly if the gene is also a lowly expressed one [67, 87] . Normalization methods which account for gene length, for example reads per kilobase per million mapped (RPKM) [42] have been developed. However, the problem cannot be corrected by simply dividing by the length of the transcript or some modification of this, as while this results in an unbiased measure of expression, the data variance is still affected in a length dependent manner. This problem has been observed for a variety of different analysis methods, experimental designs and sequencing platforms. The bias causes most problems when the results for different genes are compared, when creating ranked gene lists, or gene category over-representation analysis is undertaken; with a proposed suggestion for the latter recently published ( [87] ; discussed further below).
This bias is elevated by the fact that current technologies require both amplification and fragmentation steps for mRNA/cDNA species used in the analyses [72] . Emerging technologies such as small molecule real-time DNA sequencing (SMRT) [62, 88] and long-read sequencing such as nanopore DNA sequencing [89, 90] and direct-read genetic sequencing using Transmission Electron Microscope (http://www.zsgenetics.com) show promise to overcome this new system based bias.
Systematic biases in the bases sequenced and sequencing errors also need to be considered. These result from the combined effects of the manufacturer recommended laboratory methods, sequence read alignment tools and base calling algorithms utilized. Recent advances such as the ability to obtain longer reads and paired-end sequencing alleviate these issues, however further optimizations are desirable [64, 72] .
Available software
The tools available for RNA-Seq derived transcriptomic data analyses are not as mature yet as those for analog data. However, in this fast moving science application, software developers are rapidly closing the gap. Recently, several new software packages and modules for existing tools have been released. One of the most well known and established bioinformatic companies, DNASTAR, has recently released version 3 of its gene expression analysis software, ArrayStar (a beta version of ArrayStar 4 is also available). An optional module, QSeq (http:// www.dnastar.com/products/QSeq.php), has been developed specifically for analysis of RNA-Seq gene expression data. Data sets from the most widely used platforms such as Illumina and Roche 454 can be imported directly. The range of supported analyses includes transcript discovery and mapping, detection of alternative splicing events and transcriptome quantification. Similarly, CLCbio (http://www.clcbio.com) has released its CLC Genomics Workbench software suite which integrates genomics (genome de novo and re-sequencing), transcriptomics (RNA-Seq gene expression) and epigenomics (ChIP-seq analysis) in one environment. GenomeQuest takes a decentralized approach by offering a web-based service. Its RNA-Seq workflow (http://wiki.genomequest.com/index.php/ RNA_Seq) accesses the databases of transcriptomes and genomes while being able to utilize third-party tools such as GeneSpring and Spotfire for further analyses.
Open source software also plays an important part in the analysis of RNA-Seq data as it is able to adapt quickly to changes in technology, and is not slowed by the need to wait for official release dates like its commercial counterparts. With a large Bioconductor community developing much of this software using the R programming language ( [91, 92] , http:// www.bioconductor.org), such software is usually of similar quality to that of commercial software or may even surpass it. The DEGseq package [93] for analysing RNA-Seq data and edgeR package [82, 86] , both from the Bioconductor suite are two examples of open source software that are freely available for use in analysing RNA-Seq data. Additionally, Cufflinks (http://cufflinks.cbcb.umd .edu/; [94] ) is an open source program which can be used to assemble transcripts, estimate their abundances, and test for differential expression and regulation in RNA-Seq samples. Cufflinks is particularly useful for researchers who are interested in alternative transcript or splice variants as it can identify novel transcripts and probabilistically assign reads to isoforms without the need for prior gene annotation knowledge. Finally, the ShortRead R package and FASTX-Toolkit (http://hannonlab.cshl.edu/ fastx_toolkit/) are two freely available packages which enable quality control of short read RNA-Seq data.
FUNCTIONAL ANALYSIS OF TRANSCRIPTOMIC DATA Classification concepts
For both analog and RNA-Seq data, gene filtering methods aim to find a list of differentially expressed genes that are significantly associated with the phenotype studied. Tens to hundreds of genes, or an entire gene network, may be the causal link to a specific phenotype in response to a particular stimulus. Targeting networks which affect a given phenotype is likely to require the identification of genes that serve as key nodes in the network (key information points). There may also be interest in the response across multiple species (comparative genomics).
How variations in gene expression relate to functional changes in an organism is a question of key biological interest. Gene category over-representation analysis is a widely used method which helps determine which biological classes (functional groups) are significantly overrepresented in a gene list. The analysis comprises grouping genes into classes by some biological property, commonly Gene Ontology (GO) categories but alternatives are possible such as Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and testing whether differentially expressed genes are overrepresented in any categories [87] . This information combined with knowledge about which pathways the genes are found in, if available, can result in a powerful analysis and deepen the biological understanding of the gene-organism relationship.
Applications of gene classification
Many tools are available for gene category over-representation analysis, including GOstats [95] , FUNC [96] , EASE [97] and DAVID [98] . More comprehensive summaries are given at: http://www.geneontology.org/GO.tools.microarray.shtml and in the Supplementary Data S1 of Huang et al. [98] . Tools for specialized purposes also exist, for example AgriGO, the successor of EasyGO ( [99] ; http://bioinfo.cau.edu.cn/agriGO/), is a web-based tool which is especially useful for agricultural studies as it supports Affymetrix GeneChips for both crops and farm animals and provides excellent capabilities for visualization of the results. The general assumption underlying the methodology for each tool is that, under the null hypothesis, each gene has an equal probability of being detected as differentially expressed, hence the number of genes associated with a category that overlap with the set of differentially expressed genes follows a hypergeometric distribution [87] .
Standard gene category over-representation analysis for RNA-Seq data has the problem that genes with longer transcripts are more likely to be differentially expressed ( [67, 87] , see above) except for protocols which result in only a single transcript per gene. Thus any category with a preponderance of long genes will be more likely to be determined as over-represented than a category with shorter genes. Young et al. [87] have recently published a method which corrects for this selection bias: the likelihood of differential expression as a function of transcript length is first quantified and then incorporated in the statistical test of each category's significance either by using this information in a weighted resampling procedure or to calculate success and failure probabilities for the Wallenius non-central hypergeometric distribution. Similar results are obtained using either method; however the latter is considerably less computationally intense. Adjusting the results in this way compared to a standard GO analysis was found to have a substantial effect (20% of significant GO categories changed) on the results for a prostate cancer data set, with the adjusted results being more consistent with previous biological results. Additionally, this adjustment may be useful for both analog and RNA-Seq gene expression data with respect to more highly expressed genes or those with multiple probes for some genes, as both these factors also increase the probability of a gene being called differentially expressed [87] .
Finally, consolidating multiple probes that map to the same gene into a single count, and determining which genes to include in the 'universe' for an analysis are issues already considered for microarray data [95] and are equally important for RNA-Seq data in gene category over-representation analysis.
Applications of pathway interaction networks
Pathway analysis is also a useful tool for both analog and RNA-Seq data, as it allows the identification of nodes that are central to interactions between differentially expressed genes. Ingenuity Pathway Analysis software (IPA, Ingenuity Systems, Inc., Redwood City, CA, USA; www.ingenuity.com) is a valuable package for determining biological networks for mammalian data. Although based on human, rat and mouse data, because of species homologies, it is useful for mammalian studies in general [16, 25] . The pathway information in IPA is extracted from the scientific literature. Used in combination with gene ontology enrichment, pathway enrichment analysis, network construction and comparison analysis it can lead to novel biological insights. To use IPA, the full data set from an analysis (including gene identifications (e.g. GenBank), fold changes and FDR or P-values) is uploaded into IPA. The IPA library of canonical pathways identifies those pathways that are the most significant to the set of differentially expressed genes, as defined using selected fold change and FDR (or P-value) cut-offs. The significance of the association between this set of differentially expressed genes and a specific canonical pathway is estimated in two ways: (i) the proportion of genes in the data set included in the canonical pathway and (ii) Fisher's exact test which is used to calculate a P-value determining the probability of the association between the data set and the canonical pathway.
The IPA software was designed for microarray data. However, assuming that RNA-Seq gene expression data can be successfully mapped, it should be feasible to also use IPA for this type of data. However, it is important to note that the aforementioned problem of longer genes having a greater probability of being differentially expressed is likely to also be an issue in IPA analyses. We are not aware of a publication that currently provides a solution to this problem. It seems likely that a similar approach to that used to correct the problem for gene category over-representation analysis may be able to be used.
An interesting alternative to IPA can be found in Cytoscape (http://www.cytoscape.org/), an open source software platform for visualizing and integrating networks, biological pathways, annotation and gene expression profiles. Cytoscape's modular design means that community-based solutions can be easily incorporated via plugins, so meaning that new features are often more readily available than with commercial applications. For example, the Genoscape plugin integrates data from GenoScript (a transcriptome database) with the KEGG database to highlight gene expression changes and their respective statistical significances. While Cytoscape was originally designed for biologists, more recent versions have expanded its functionality to a general platform for network analyses. This will potentially facilitate the development of novel plugins with a synergy effect beyond their original purpose.
Finally, network language can also be used to describe pair-wise relationships among genes and to cluster genes with similar expression patterns into pathways or regulatory networks, which can be depicted in heat maps. A heat map is a commonly used tool to visualize data generated from microarrays, and potentially RNA-Seq data, reflecting the level of expression of many genes across a number of comparable samples (e.g. different physiological status, different breeds, etc.) in a graphical representation where the changes in values of the chosen variable are represented as colours in a two-dimensional map [100, 101] .
CONCLUSION
The analysis of gene expression has evolved from the investigation of individual genes over the analysis of thousands of genes to know the measurement of potentially all genes in a sample. While these technologies promise a much deeper understanding of the intricate relationships between gene expression and internal and external stimuli, the rapidly increasing amount of data to be analysed and to be put in context creates veritable challenges to biologists and bioinformaticians. As the cost of storing data becomes prohibitive, concepts such as cloud computing may become critical for the success of future RNA-Seq experiments. Integrating the data from both microarray and RNA-Seq experiments with other 'omics' data sets open up new possibilities for creating meaningful informational networks which will aid our understanding of biological systems.
SUPPLEMENTARY DATA
Supplementary data are available online at http:// bfgp.oxfordjournals.org/.
Key Points
DNA and oligonucleotide microarray (chip) technology is a high-throughput analog method that has become a standard tool for the analysis of genome-wide expression patterns, whether there is a sequenced genome or not, to establish gene networks and identify new genes involved in a phenotype. As microarrays are an analog technology, they have certain limitations. For example, they rely on hybridization which affects their ability to detect low abundance genes or distinguish alternative forms. Also, the knowledge obtained is restricted to the tiled genes. However, the lower cost and established protocols of microarray technology mean that it currently remains a viable option.
RNA-Seq is an emerging method for fully quantitative transcriptomic analysis (i.e. transcripts are counted) and has the potential to overcome the limitations of microarray technology, eventually replacing these analog methods. It is clear that RNA-Seq may be the new Gold standard. However, the data volume is increased by several magnitudes, while the tools available for data analyses are not yet as mature as those used for microarray analyses. Changes in technological platforms often require the development of naive software and analysis applications and care must be taken when applying algorithms developed for different underlying principles. Gene category over-representation analysis and pathway analysis are useful tools for analysing gene expression data from microarrays or RNA-Seq and deepen the understanding of the gene^organism relationship.
